Embody vs Gala: Which GLP-1 Provider Is Better?
Short answer: Embody scores higher on our rubric, 7.3/10 against 7.2/10. Full reasoning, pricing and the cases where the other one wins are below.
Embody beats Gala overall, scoring 7.3/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Gala is from $149/mo. Choose Embody for people comfortable committing to a term, since embody's cheapest rates are its twelve-month plans, and who want the commitment stated up front rather than implied. Choose Gala for patients who want gala's low yearly-plan rate on compounded glp-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging.
A side-by-side look at Embody and Gala to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Embody
#28 of 54Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan.
Visit EmbodyGala
#30 of 54Telehealth platform whose compounded GLP-1 line covers semaglutide and tirzepatide, sold as a $149/mo microdose tier and a $179/mo all-doses tier, alongside brand-name Ozempic at $1,299/mo and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. of Wilmington, Delaware, with care delivered by OpenLoop-affiliated medical groups; Gala states it provides administrative, technology and management services and does not itself provide medical care. It is LegitScript verified and promotes a free Gala GLP-1 app for in-treatment dosing, weight and side-effect logging.
Visit Gala| Feature | Embody | Gala |
|---|---|---|
| Why each one | Publishes a complete four-tier price ladder for both molecules, so the commitment behind every advertised rate is checkable rather than implied. | A free Gala GLP-1 companion app, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; confirm the app's availability for your phone before enrolling. |
| Our Score | 7.3/10 | 7.2/10 |
| Headline Price | from $69/mo | from $149/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | People comfortable committing to a term, since Embody's cheapest rates are its twelve-month plans, and who want the commitment stated up front rather than implied | Patients who want Gala's low yearly-plan rate on compounded GLP-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging |
| Watch out for | Everything you pay is non-refundable. Embody's refund policy, dated August 25, 2026, says all payments are final at the time of purchase, that cancelling stops future billing only, and that multi-month plans are non-refundable in whole and in part, so the twelve-month plan commits $828 up front and cancellations have to reach support at least 72 hours before the next billing date. | Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line. |
| Ranking | #28 | #30 |
| Get started | Visit Embody | Visit Gala |
Pros & Cons Compared
Embody
Pros
- +Publishes a complete price ladder for both molecules, so what each advertised rate costs up front is checkable: semaglutide $79/$76/$73/$69 and tirzepatide $129/$126/$123/$119 across one, three, six and twelve months.
- +Advertised injection floors of $79 for semaglutide and $129 for GLP-1 + GIP, verified August 14, 2026. The FAQ says the selected rate holds within the chosen plan.
- +Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
- +Publishes its cancellation and refund terms in full, dated August 25, 2026, so the 72-hour cancellation cutoff and the all-sales-final rule are readable before you pay.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −Everything you pay is non-refundable. Embody's refund policy, dated August 25, 2026, says all payments are final at the time of purchase, that cancelling stops future billing only, and that multi-month plans are non-refundable in whole and in part, so the twelve-month plan commits $828 up front and cancellations have to reach support at least 72 hours before the next billing date.
- −The $79/$129 figures are advertised floors tied to a selected 4-, 12-, 24- or 52-week plan, not a verified no-commitment month-to-month rate. Confirm the plan length and total before payment.
- −Trustpilot rating is 3.7 / 5 across 6,825 reviews, checked 2026-09-03, while the landing page advertises 4.8. Price and billing remain recurring complaint themes, although many reviews describe earlier pricing structures.
- −Embody names four partner pharmacies: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama, and says all four are 503A compounding pharmacies. It does not say which one will fill your prescription. Triad Rx received a 2019 FDA warning letter for sterile-production violations, and the FDA close-out in May 2023 records that the firm no longer produces sterile drug products.
- −Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −Modern Metabolic Medicine, Inc. also runs SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com). Each footer names the shared parent, but none of the three names the others, and SnagRx sells the same compounded semaglutide and tirzepatide at the same $69 and $119 prices Embody's own landing page shows. See our [SnagRx review](/reviews/snagrx)
Gala
Pros
- +Compounded GLP-1 is $149/mo on the microdose tier or $179/mo with all doses included on the yearly plan, and Gala's about page lists GLP-1 medication from $199/mo on a 3-month plan
- +A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
- −Product pages quote only the yearly subscription, its about page lists a 3-month GLP-1 plan from $199/mo, and the plan you actually get is set at checkout after you log in
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and Gala publishes no lab panel for the GLP-1 program, no named medical director and no specialty obesity oversight; its refund policy does list lab services among what the subscription price may cover
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Our Verdict
Embody edges out Gala with a score of 7.3/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Gala is from $149/mo. Gala offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Embody and Gala.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Embody and GoodRx Care$119/mo subscription + medication
- Compare Embody and Strut Healthfrom $99/mo
- Compare Embody and SnagRxpublished $99/mo; total not verified
- Compare Gala and TMatesfrom $158/mo
- Compare Gala and DudeMedsfrom $149/mo
- Compare Gala and Hers$188 first month, then $298/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Embody legit and is Gala legit, with the verification evidence behind each answer.
Our pick of these two: Embody · 7.3/10